US$ 29.69
compounding glp-1 Managing Compounded Medications: A Pharmacist's Guide for Employers – Sequoia Novo Nordisk asks FDA not
Description
Early initiation of metformin treatment plus an SGLT-2 inhibitor is recommended in most people with type 2 diabetes, followed by the addition of glucose-lowering agents as needed to achieve individualised glycaemic targets (Table 2)

Phentermine is a reasonable first-line option

JAMA 330 , 512527 (2023)

Remove the patch from its liner

Blackman et al

It makes a lot of sense due to the difference in response and tolerance rates among people who are taking GLP-1 medications
